KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 002907.SZ
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Chongqing Pharscin Pharmaceutical Co Ltd stock downgraded after the last trading session.
(Updated on Apr 26, 2024)

Sell candidate since Apr 26, 2024 PDF

The Chongqing Pharscin Pharmaceutical Co Ltd stock price fell by -0.300% on the last day (Friday, 26th Apr 2024) from ¥13.35 to ¥13.31. During the last trading day the stock fluctuated 6.90% from a day low at ¥12.61 to a day high of ¥13.48. The price has risen in 6 of the last 10 days but is still down by -1.55% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -708 thousand shares and in total, 3 million shares were bought and sold for approximately ¥37.46 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.52% during the next 3 months and, with a 90% probability hold a price between ¥12.42 and ¥17.11 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

002907.SZ Signals & Forecast

There are mixed signals in the stock today. The Chongqing Pharscin Pharmaceutical Co Ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at ¥14.00. On a fall, the stock will find some support from the short-term average at ¥13.06. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, March 18, 2024, and so far it has fallen -13.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Chongqing Pharscin Pharmaceutical Co Ltd stock

Chongqing Pharscin Pharmaceutical Co Ltd finds support from accumulated volume at ¥13.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved ¥0.87 between high and low, or 6.90%. For the last week, the stock has had daily average volatility of 6.28%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (002907.SZ) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Chongqing Pharscin Pharmaceutical Co Ltd to open at ¥13.13, and during the day (based on 14 day Average True Range), to move between ¥12.54 and ¥14.08, which gives a possible trading interval of +/-¥0.774 (+/-5.82%) up or down from last closing price. If Chongqing Pharscin Pharmaceutical Co Ltd takes out the full calculated possible swing range there will be an estimated 11.63% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at ¥13.30 (0.08%) than the resistance at ¥14.56 (9.39%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Chongqing Pharscin Pharmaceutical Co Ltd stock A Buy?

Chongqing Pharscin Pharmaceutical Co Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -4.184 Sell Candidate Downgraded

Predicted Opening Price for Chongqing Pharscin Pharmaceutical Co Ltd of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
¥13.13 ( 1.33%) ¥13.31

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 002907.SZ

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 14.00 5.21 %
R2 13.67 2.71 %
R1 13.47 1.17 %
Current price: 13.31
Support S1 12.80 -3.82 %
S2 12.60 -5.37 %
S3 12.26 -7.86 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.76 10.89 %
R2 14.69 10.37 %
R1 14.56 9.39 %
Current price 13.31
Support S1 13.30 -0.0751%
S2 13.09 -1.65%
S3 11.43 -14.12%

002907 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 13, 2023 Jun 13, 2023 Jun 13, 2023 ¥0.0700 0.465%
2 Jul 14, 2022 Jul 14, 2022 Jul 14, 2022 ¥0.0500 0.361%
3 Jun 24, 2021 Jun 24, 2021 Jun 24, 2021 ¥0.0280 0.210%
4 Jul 17, 2020 Jul 17, 2020 Jul 17, 2020 ¥0.0440 0.251%
5 Apr 26, 2019 Apr 26, 2019 Apr 26, 2019 ¥0.0350 0.176%

FAQ

What is the symbol for Chongqing Pharscin Pharmaceutical Co Ltd Stock and on which exchange is it traded?
The symbol for Chongqing Pharscin Pharmaceutical Co Ltd is 002907.SZ and it is traded on the SZCE (Shenzhen Stock Exchange).

Should I buy or sell Chongqing Pharscin Pharmaceutical Co Ltd Stock?
Chongqing Pharscin Pharmaceutical Co Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Chongqing Pharscin Pharmaceutical Co Ltd Stock?
Chongqing Pharscin Pharmaceutical Co Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Chongqing Pharscin Pharmaceutical Co Ltd Stock.

What's the current price of Chongqing Pharscin Pharmaceutical Co Ltd Stock?
As of the end of day on the Apr 26, 2024, the price of an Chongqing Pharscin Pharmaceutical Co Ltd (002907.SZ) share was ¥13.31.

What is the 52-week high and low for Chongqing Pharscin Pharmaceutical Co Ltd Stock?
The 52-week high for Chongqing Pharscin Pharmaceutical Co Ltd Stock is ¥20.50 and the 52-week low is ¥9.82.

What is the market capitalization of Chongqing Pharscin Pharmaceutical Co Ltd Stock?
As of the Apr 26, 2024, the market capitalization of Chongqing Pharscin Pharmaceutical Co Ltd is 5.558B.

When is the next earnings date for Chongqing Pharscin Pharmaceutical Co Ltd?
The upcoming earnings date for Chongqing Pharscin Pharmaceutical Co Ltd is May 22, 2024.
Click to get the best stock tips daily for free!

About Chongqing Pharscin Pharmaceutical Co Ltd

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, hard capsules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, and API synthesis. It provides its products in the areas of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharsc... 002907.SZ Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT